Avoiding common pitfalls in the clinical development of cell therapies is essential to keeping site activation, recruitment and trial completion on track. In this newly published whitepaper, Medpace experts discuss challenges and strategies for success in cell therapy clinical development.
A range of topics are covered including:
- Capacity and Experience of Clinical Resources
- Reaching Clinical Trial Participants
- Capacity and Standardization of Manufacturing
- Managing Complex Logistics
- Early Development of Regulatory Strategy
Read more about the challenges of cell therapies, along with the best ways to mitigate the risk of common pitfalls.
We also invite you to contact Medpace to discuss your upcoming development projects. We are a global CRO with extensive experience in the clinical development of cellular and gene therapies. We offer Sponsors an experienced team of experts who take an active role in the field and are at the forefront of rapidly changing clinical and regulatory developments.
Medpace Cellular & Gene Therapy Clinical Development
Medpace has been a pioneer in the clinical development of cellular and gene therapies, with experience contributing to over 130 clinical trials across numerous therapeutic areas and global regions. This experience has given Medpace a strong strategy for avoiding and mitigating cell therapy risks. The team of experts offers comprehensive solutions to the unique and rapidly evolving clinical, operational and regulatory challenges of cellular, tissue and gene therapy medicines.